2020 Annual Meeting | C21 - Approaching the Management of Common Sleep Disorders

Date Saturday 04/25/20

Time 09:30 AM - 11:30 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Logan D. Schneider, MD

Topic(s) Sleep

Learning Objectives Participants should become familiar with historical elements suggestive of circadian rhythm disorders, restless legs syndrome, and hypersomnolence (vs hypersomnia); be able to educate their patients on healthy sleep-wake scheduling and behaviors; and be able to choose appropriate diagnostics, referrals, and first-line treatments for common sleep-wake disorders recognized in their patients.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Program Tracks Advanced Practice Provider

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Didactic

Event Timeline
09:30 AM - 09:35 AM	Introduction	Common Things You’ll Miss if You Don't Look or Ask About Logan D. Schneider, MD
09:35 AM - 10:10 AM	Speaker	Circadian Rhythm Optimization for Neurologic Health Across the Lifespan Michelle B. Jonelis, MD
10:10 AM - 10:45 AM	Speaker	The Compulsive Use of Dopamine Agonists for Restless Legs Syndrome: 21st-century RLS Management Joseph A. Berkowski, MD
10:45 AM - 11:20 AM	Speaker	How to Think About Your Sleepy Patient LynnMarie Trotti, MD
11:20 AM - 11:30 PM	Q&A	Questions and Answers

Faculty Disclosures
Logan D. Schneider, MD	Dr. Schneider has received personal compensation for serving as an employee of Alphabet, Inc. Dr. Schneider has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Avadel Pharmaceuticals. Dr. Schneider has received intellectual property interests from a discovery or technology relating to health care.
LynnMarie Trotti, MD	Dr. Trotti has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for American Academy of Sleep Medicine. Dr. Trotti has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Association of Chest Physicians. The institution of Dr. Trotti has received research support from NIH. The institution of Dr. Trotti has received research support from American Academy of Sleep Medicine Foundation . Dr. Trotti has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with AASM, CHEST, Medscape, SRS Foundation, PER CME, Haymarket CME. Dr. Trotti has received personal compensation in the range of $0-$499 for serving as a DSMB member with NIH. Dr. Trotti has received personal compensation in the range of $0-$499 for serving as a Reviewer with Lancet journals. Dr. Trotti has a non-compensated relationship as a Medical advisory board member with Hypersomnia Foundation that is relevant to AAN interests or activities. Dr. Trotti has a non-compensated relationship as a Board member with AASM Foundation that is relevant to AAN interests or activities. Dr. Trotti has a non-compensated relationship as a Board member with ABSM that is relevant to AAN interests or activities.
Michelle B. Jonelis, MD	Dr. Jonelis has nothing to disclose.
Joseph A. Berkowski, MD	Dr. Berkowski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Meahger and Geer, PLLP. Dr. Berkowski has a non-compensated relationship as a Member of Scientific and Medical Advisory Board with Restless Legs Syndrome Foundation that is relevant to AAN interests or activities.

��ɫ��

��ɫ��